Health Technology · Pharmaceuticals: Other · NSE: NATCAPSUQ · data 2026-10-09

Natural Capsules Limited

Health check: Weak (1.7/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹160.01

Market cap

₹166 cr

P/E

—

P/B

—

ROE

-7.5%

ROCE

-6.4%

Debt / equity

0.52

Dividend yield

0.00%

1-year return

-34.1%

52-week high

₹239

52-week low

₹136.36

Operating margin

-9.4%

Growth

Revenue (last 12 months)	₹191 cr
Net profit (last 12 months)	₹-22 cr
Sales growth, 3 years (yearly)	3.2%
Profit growth, 3 years (yearly)	—

Similar companies

Amrutanjan Health Care Limited (AMRUTANJAN) · Shri Ahimsa Naturals Limited (SHRIAHIMSA) · Influx Healthtech Limited (INFLUX) · Lyka Labs Limited (LYKALABS) · Sat Kartar Life Limited (SATKARTAR)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open NATCAPSUQ in NSE Scanner →